Healthcare expenditure, UK Health Accounts provisional estimates: 2021

Provisional high-level estimates of healthcare expenditure in 2021 by financing scheme.

Hwn yw'r datganiad diweddaraf. Gweld datganiadau blaenorol

Cyswllt:
Email James Cooper

Dyddiad y datganiad:
9 May 2022

Cyhoeddiad nesaf:
To be announced

1. Main points

  • Total current healthcare expenditure in 2021 is estimated at £277 billion, which is an increase in nominal terms of 7.4% on spending in 2020.

  • Adjusting for the effects of inflation in the overall economy, total current healthcare expenditure in real terms grew by 7.1% in 2021, compared with 10.0% in 2020. 

  • The share of gross domestic product (GDP) attributed to healthcare was around 11.9% in 2021, which is similar to the share in 2020.

  • Government healthcare expenditure is estimated to have increased by 7.5% (in nominal terms) in 2021; this is likely to have been driven in part by activities in response to the coronavirus (COVID-19) pandemic, such as testing and tracing services and the implementation of the vaccination programme. 

  • Non-government healthcare expenditure is estimated to have grown by around 7.0% in nominal terms over 2021, following a fall of 3.9% in 2020.

Nôl i'r tabl cynnwys

2. Total current healthcare expenditure

Healthcare expenditure in 2021

Our early estimates suggest that spending on healthcare in the UK in 2021 was approximately £277 billion, including both government and non-government spending. These early estimates are based on initial data and therefore subject to a greater degree of uncertainty than figures published in our Healthcare expenditure, UK Health Accounts 2020 bulletin.

As a result of the provisional nature of these estimates, and the data used to produce them, users should be aware that our 2021 figures may be subject to substantial revisions one year after release, when the complete set of data sources used to produce the full health accounts are published.

This bulletin presents high-level analysis of healthcare spending by financing schemes. The latest analysis of healthcare expenditure by healthcare function and provider is available in our full health accounts for 2020. While our 2021 estimates include spending on health-related long-term care, we are unable to provide estimates for total long-term care expenditure.

Healthcare expenditure grew in 2021, but less rapidly than in 2020

Total healthcare expenditure grew by 7.4% in nominal terms between 2020 and 2021. Total healthcare spending in 2021 was around 24% (£54 billion) greater than the amount spent in 2019, before the coronavirus (COVID-19) pandemic.

The increase in total current healthcare expenditure was primarily driven by government expenditure, reflecting the UK and devolved governments’ response to the coronavirus pandemic. However, there was also growth in non-government financing schemes, as the provision of privately funded healthcare began to recover following a fall in non-government spending in 2020.

After adjusting for general inflation within the economy, real terms healthcare spending in 2021 increased by 7.1%, compared with growth of 10.0% in 2020.

Healthcare expenditure represented around 12% of GDP in 2021

Healthcare expenditure can also be measured as a share of gross domestic product (GDP), to show healthcare spending relative to the whole economy. Healthcare expenditure represented 11.9% of GDP in 2021, around the same share as in 2020 (12.0%). This reflected the fact that nominal growth in healthcare expenditure broadly matched the strong growth in the overall economy in 2021.

The share of GDP attributable to healthcare is still much greater than before the coronavirus pandemic. Between 2009 and 2019, healthcare expenditure accounted for around 10% of the overall economy.

Figure 2: Healthcare spending as a share of GDP remained at around 12% in 2021, because of GDP and healthcare spending growing by similar rates

Share of GDP attributed to total current healthcare expenditure and growth contributions, UK, 1997 to 2021

Embed code

Notes:

  1. Nominal GDP growth contribution is inverted relative to the direction of GDP growth. For instance, a fall in GDP will be shown as a positive contribution of GDP growth to the change in healthcare expenditure as a percentage of GDP.
Download the data

.xlsx

Nôl i'r tabl cynnwys

3. Government healthcare expenditure

Government healthcare expenditure in 2021 was higher than in any other year

Our initial estimates suggest that government healthcare spending in 2021 was in the region of £229 billion, accounting for over four-fifths (83%) of total healthcare expenditure. This was higher than spending in any other year, including 2020. In 2021, healthcare spending represented around 45% of overall government spending on goods and services in the UK (General Government final consumption expenditure). This figure, using the definitions of the System of Health Accounts 2011, includes many long-term care services typically considered as social care in the UK.

Year-on-year growth in this measure of government healthcare expenditure in 2021 was 7.5%, relative to 20.7% in 2020. Adjusting for general inflation within the economy, relative growth in healthcare spending was reduced to 7.2% in 2021 and 14.9% in 2020.

Growth in government healthcare activity

Nominal healthcare expenditure growth reflects a combination of changes in the costs of providing services and the quantity of services provided. It should be noted that while our real terms estimates of healthcare spending are adjusted for changes in costs within the overall economy, they do not necessarily reflect the changes in the costs of health-specific goods and services.

There was particularly substantial growth between 2020 and 2021 in the activity of new services created in response to the coronavirus (COVID-19) pandemic. There were more than seven times as many registered coronavirus tests recorded under Pillars One and Two of the government testing strategy in 2021 than in 2020, reflecting an increase in the volume of laboratory-processed tests performed and the delivery of lateral flow devices through the mass testing scheme. There was an even greater growth in the number of coronavirus vaccinations delivered from 2020, when vaccinations were provided in December only, to 2021. Published data show around 2.7 million vaccines were administered up to 10 January 2021, compared with 133.3 million by the end of 2021.

As well as the growth in new services created in response to the coronavirus pandemic, activity levels across a range of existing healthcare services increased between 2020 and 2021. Most notably there was strong growth in the number of elective treatments and A&E attendances over 2021, following substantial falls in 2020.

Nôl i'r tabl cynnwys

4. Non-government healthcare expenditure

Growth in non-government healthcare expenditure varied by financing scheme

Expenditure on healthcare financed through non-government schemes was approximately £47 billion in 2021, an increase of roughly 7.0% in nominal terms on 2020. Of the two non-government schemes that represent consumer spending, out-of-pocket healthcare expenditure increased by around 5.3% and voluntary health insurance schemes by 10.4%, both rebounding after falls in spending in 2020.

Based on trends observed in early estimates of household final consumption expenditure, household spending on outpatient and hospital services, which include self-funded and insurance-funded treatments, grew by 24.5% and 31.3% respectively in 2021. This strong growth was offset slightly by little observable growth in spending on medical goods between 2020 and 2021.

Nôl i'r tabl cynnwys

5. Revisions

Estimates previously published in our Healthcare expenditure, UK Health Accounts provisional estimates: 2020 bulletin have now been revised to incorporate newly available, more complete data and are available in our Healthcare expenditure, UK Health Accounts: 2020 bulletin. That bulletin also includes analysis of revisions from the provisional estimates published in 2021 to the revised estimates published this year.

Nôl i'r tabl cynnwys

6. Healthcare expenditure data

UK Health Accounts
Dataset | Released 9 May 2022 UK health expenditure. Final data for financing schemes, functions, providers, long-term care expenditure, revenues of financing and capital expenditure. Provisional data for financing schemes only.

Nôl i'r tabl cynnwys

7. Measuring the data

Data for 2021 presented in this bulletin are consistent with the System of Health Accounts 2011 framework used to produce UK health accounts between 1997 and 2020. For more information about the sources and methods used to produce our 2021 estimates of healthcare expenditure, please see our UK Health Accounts: methodological guidance for t-1 estimates of healthcare expenditure article.

Nôl i'r tabl cynnwys

8. Strengths and limitations

Timeliness

We have produced early estimates of healthcare expenditure in 2021 to present more timely data on the healthcare sector in the UK that are consistent with our main series of health accounts, which runs from 1997 to 2020.

Data availability

The data presented in this report are based on growth presented in quarterly national accounts data. These early estimates are subject to data revisions, reflecting the inherent trade-off between timeliness and accuracy of different data sources. Quarterly national accounts data are subject to revision, as explained in the National Accounts revision policy.

Impact of coronavirus (COVID-19)

Estimates of expenditure in 2021 are subject to more uncertainty than usual as a result of the challenges faced by data providers in collecting data over this year.

Nôl i'r tabl cynnwys

Manylion cyswllt ar gyfer y Bwletin ystadegol

James Cooper
healthaccounts@ons.gov.uk
Ffôn: +44 1633 456551